Cargando…
2215. Impact of a Pharmacy-Driven Penicillin Allergy De-Labeling Pilot Program in Pre-Operative Cardiothoracic and Spine Surgery Patients at a Quaternary Hospital
BACKGROUND: Studies suggest up to 95% of patients with a reported penicillin (PCN) allergy can tolerate PCNs. Documented PCN allergies are associated with increased risks including Clostridioides difficile infections (CDI) and surgical site infections (SSIs). The goal of this study is to evaluate th...
Autores principales: | Crum, Hannah, Gagnon, Brandon, Gens, Krista |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679323/ http://dx.doi.org/10.1093/ofid/ofad500.1837 |
Ejemplares similares
-
171. Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program
por: Song, Youchan, et al.
Publicado: (2020) -
Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program without Skin Testing or Oral Challenges
por: Song, You-Chan, et al.
Publicado: (2021) -
TDV-2215
Publicado: (1980) -
Heterogeneity in direct oral penicillin challenge protocols in penicillin allergy de-labelling
por: Bhogal, Rashmeet, et al.
Publicado: (2021) -
1252. Penicillin Allergy Reassessment for Treatment Improvement (PARTI): A Dental Office Tool to Support Appropriate Penicillin Allergy Labeling
por: Coyne, Ashlan J Kunz, et al.
Publicado: (2023)